V
ViroGates A/S
CSE:VIRO
ViroGates A/S
CSE:VIRO
Price:
12.3
DKK
-1.2%
Market Closed
Market Cap:
kr114.1m
Relative Value
The Relative Value of one VIRO stock under the Base Case scenario is 1.49 DKK. Compared to the current market price of 12.3 DKK, ViroGates A/S is Overvalued by 88%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VIRO
Relative Value
Base Case
1.49
DKK
Overvaluation 88%
V
Multiples Across Competitors
VIRO Competitors Multiples
ViroGates A/S Competitors
ViroGates A/S Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DK |
V
|
ViroGates A/S
CSE:VIRO
|
114.1m DKK | 22.6 | -9.2 | -8.7 | -8.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
202.2B USD | 4.6 | 31 | 17.5 | 23.9 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
178.4B USD | 17.7 | 62.5 | 47.5 | 58.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
148B USD | 5.9 | 45.6 | 23 | 27.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
124.9B USD | 3.5 | 27.1 | 14.6 | 21.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
113.5B USD | 5.7 | 39.1 | 23.2 | 31.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.8B EUR | 2 | 22.5 | 12.4 | 17.4 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
52.7B USD | 12.3 | 49.8 | 35.6 | 39.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.3B USD | 2.3 | 28.6 | 11 | 18.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
50.3B USD | 8.3 | 46.8 | 26.1 | 28.5 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD | 1.9 | 18.4 | 13 | 15.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
